Skip to Main Content
Back to News

Lobbying Update: $50,000 of VAXART INC. lobbying was just disclosed

None

$50,000 of VAXART INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Vaccine policy."

You can find more data on corporate lobbying on Quiver Quantitative.

VXRT Insider Trading Activity

VXRT insiders have traded $VXRT stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $VXRT stock by insiders over the last 6 months:

  • STEVEN LO (President, Chief Exec Officer) purchased 100,000 shares for an estimated $49,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

VXRT Hedge Fund Activity

We have seen 26 institutional investors add shares of VXRT stock to their portfolio, and 35 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

VXRT Analyst Ratings

Wall Street analysts have issued reports on $VXRT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • B. Riley Securities issued a "Buy" rating on 03/27/2025

To track analyst ratings and price targets for VXRT, check out Quiver Quantitative's $VXRT forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles